Client: U.K. Department of Health and Social Care
Duration: 2019-2025
Region: Asia and the Pacific
Country: Pakistan
Solutions: Global Health
The Fleming Fund is a U.K. Department of Health and Social Care program to help low- and middle-income countries fight antimicrobial resistance (AMR). The Fund is administered through Mott Macdonald.
DAI’s Fleming Fund program in Pakistan is a collaboration with the Pakistani government to strengthen systems using a “One Health” approach—a multisectoral approach to complex health problems that reach across human health, animal health, and environment sectors. As global leaders in One Health, the DAI team helps incorporate One Health across program interventions, supporting Pakistan in becoming a leader in combating antimicrobial resistance and a model for better management of antimicrobials in human and animal populations.
Upon successful completion of Fleming Fund Phase I, the UK Department of Health and Social Care approved DAI’s application to lead the Fleming Fund Phase II Country Grant in Pakistan for an additional two years (January 2024 to December 2025).
Phase I focused on enhancing laboratory infrastructure, strengthening human resources and workforce reforms, strengthening AMR and antimicrobial use surveillance systems, building foundations for AMR surveillance data, and promoting rational use of antimicrobial medicines. Phase II will pursue intermediate outcomes relating to the quality data produced for antimicrobial resistance/consumption/use and burden, quality data analysis conducted, and quality data analysis shared with decision-makers to progress towards the long-term outcome of sustainable investment at country and global levels to counter AMR.
DAI serves as the lead grantee responsible for the project’s overall technical, financial, and management implementation. Fleming Fund Pakistan’s other partners include the Liverpool School of Tropical Medicine, Health Security Partners, Indus Hospital Health Network, and Shifa International Hospital.
RELATED CONTENT:
The Integrated Pharmaceutical and Supply Chain Technical Assistance Activity works to ensure more sustainable access to—and appropriate use of—quality-assured and affordable health commodities in Kenya by supporting the development of an increasingly resilient and mature supply chain system and pharmaceutical regulatory services.
Read More